An experienced biotech executive and scientist with 15+ years of drug development experience, starting as a co-founder of Oncolytics Biotech Inc. Successfully drove initial laboratory observations of an oncolytic reovirus to Phase I studies and subsequently through to large multinational studies. Experienced in tech transfer, Company creation, and public markets financing. Successful in leading multidisciplinary teams in manufacturing, pre-clinical and clinical development and regulatory affairs.